Site-specific basicities regulate molecular recognition in receptor binding: In silico docking of thyroid hormones

European Biophysics Journal

Volumn 42, Issue 9, 2013, Pages 721-730

  Tóth, Gergo ^a   Baska, Ferenc ^a,b   Schretner, András ^a   Rácz, Ákos ^a   Noszál, Béla ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Vichem Chemie Research Ltd   (Hungary)

Author keywords

Microspeciation; Molecular modeling; Protein binding; Receptor binding; Thyroid; Thyroxine

Indexed keywords

3 3 5 TRIIODOTHYRONINE; AMINO ACID RECEPTOR; CARBOXYL GROUP; CHOLESTEROL; HORMONE RECEPTOR; LIOTHYRONINE; THYROID HORMONE; THYROXINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PH; CHOLESTEROL BLOOD LEVEL; COMPUTER MODEL; DRUG DESIGN; HEART RATE; HYDROGEN BOND; IONIZATION; METABOLIC RATE; MOLECULAR MODEL; MOLECULAR RECOGNITION; PROTEIN BINDING; PROTON TRANSPORT; RECEPTOR AFFINITY; RECEPTOR BINDING; SEPARATION TECHNIQUE; TRIACYLGLYCEROL BLOOD LEVEL; X RAY CRYSTALLOGRAPHY;

HYDROGEN-ION CONCENTRATION; MOLECULAR DOCKING SIMULATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, THYROID HORMONE; SUBSTRATE SPECIFICITY; THYROID HORMONES;

EID: 84896691244     PISSN: 01757571     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00249-013-0921-1     Document Type: Article

References (49)

1. Andrea TA, Dietrich SW, Murray WJ, Kollman PA, Jorgensen EC, Rothenberg S (1979) A model for thyroid hormone-receptor interactions. J Med Chem 22(3):221-232. doi: 10.1021/jm00189a002
2. Bartalena L (1990) Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 11(1):47-64. doi: 10.1210/edrv-11-1-47
3. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23(1):38-89. doi: 10.1210/er.23.1.38
4. Bleicher L, Aparicio R, Nunes FM, Martinez L, Gomes Dias SM, Figueira AC, Santos MA, Venturelli WH, da Silva R, Donate PM, Neves FA, Simeoni LA, Baxter JD, Webb P, Skaf MS, Polikarpov I (2008) Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. BMC Struct Biol 8:8. doi: 10.1186/1472-6807-8-8
5. Borngraeber S, Budny MJ, Chiellini G, Cunha-Lima ST, Togashi M, Webb P, Baxter JD, Scanlan TS, Fletterick RJ (2003) Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc Natl Acad Sci USA 100(26):15358-15363. doi: 10.1073/pnas.2136689100
6. Boyer SH, Jiang H, Jacintho JD, Reddy MV, Li H, Li W, Godwin JL, Schulz WG, Cable EE, Hou J, Wu R, Fujitaki JM, Hecker SJ, Erion MD (2008) Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs. J Med Chem 51(22):7075-7093. doi: 10.1021/jm800824d
7. Cody V (1980) Thyroid hormone interactions: molecular conformation, protein binding, and hormone action. Endocr Rev 1(2):140-166. doi: 10.1210/edrv-1-2-140
8. Cunha Lima ST, Rodrigues ED (2011) The oligomeric state of thyroid receptor regulates hormone binding kinetics. J Endocrinol 210(1):125-134. doi: 10.1530/JOE-11-0019
9. Cunha Lima ST, Nguyen NH, Togashi M, Apriletti JW, Nguyen P, Polikarpov I, Scanlan TS, Baxter JD, Webb P (2009) Differential effects of TR ligands on hormone dissociation rates: evidence for multiple ligand entry/exit pathways. J Steroid Biochem Mol Biol 117(4-5):125-131. doi: 10.1016/j.jsbmb.2009.08.003
10. de Araujo AS, Martinez L, de Nicoluci Paula R, Skaf MS, Polikarpov I (2010) Structural modeling of high-affinity thyroid receptor-ligand complexes. Eur Biophys J 39(11):1523-1536. doi: 10.1007/s00249-010-0610-2
11. de Vijlder JJ, den Hartog MT (1998) Anionic iodotyrosine residues are required for iodothyronine synthesis. Eur J Endocrinol 138(2):227-231. doi: 10.1530/eje.0.1380227
12. Dow RL, Schneider SR, Paight ES, Hank RF, Chiang P, Cornelius P, Lee E, Newsome WP, Swick AG, Spitzer J, Hargrove DM, Patterson TA, Pandit J, Chrunyk BA, LeMotte PK, Danley DE, Rosner MH, Ammirati MJ, Simons SP, Schulte GK, Tate BF, DaSilva-Jardine P (2003) Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics. Bioorg Med Chem Lett 13(3):379-382. doi: S0960894X02009472
13. Du J, Qin J, Liu H, Yao X (2008) 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta. J Mol Graph Model 27(2):95-104. doi: 10.1016/j.jmgm.2008.03.003
14. Erion MD, Cable EE, Ito BR, Jiang H, Fujitaki JM, Finn PD, Zhang BH, Hou J, Boyer SH, van Poelje PD, Linemeyer DL (2007) Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci USA 104(39):15490-15495. doi: 10.1073/pnas.0702759104
15. Farwell PA, Braerman LE (2006) Thyroid and antithyroid drugs. In: Goodman LS, Gilman A, Brunton LL, Lazo JS, Parker KL (eds) Goodman & Gilman's the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 1563-1596
16. Forrest D, Vennstrom B (2000) Functions of thyroid hormone receptors in mice. Thyroid 10(1):41-52. doi: 10.1089/thy.2000.10.41
17. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739-1749. doi: 10.1021/jm0306430
18. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49(21):6177-6196. doi: 10.1021/jm051256
19. Glide (2011) Glide version 5.7, Schrödinger, LLC, New York, NY
20. Halgren TA (1999) MMFF94s option for energy minimization studies. J Comput Chem 20(1):720-729. doi: 10.1002/(SICI)1096-987X(199905)20:7<720::AID- JCC7>3.0.CO;2-X
21. Hangeland JJ, Doweyko AM, Dejneka T, Friends TJ, Devasthale P, Mellstrom K, Sandberg J, Grynfarb M, Sack JS, Einspahr H, Farnegardh M, Husman B, Ljunggren J, Koehler K, Sheppard C, Malm J, Ryono DE (2004) Thyroid receptor ligands. Part 2: thyromimetics with improved selectivity for the thyroid hormone receptor beta. Bioorg Med Chem Lett 14(13):3549-3553. doi: 10.1016/j.bmcl.2004. 04.032
22. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ (2001) Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22(4):451-476. doi: 10.1210/er.22.4.451
23. Jorgensen WL, Tirado-Rives J (1988) The OPLS force field for proteins. Energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110(6):1657-1666. doi: 10.1021/ja00214a001
24. Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL (2001) Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 105(28):6474-6487. doi: 10.1021/jp003919d
25. Latham KR, Ring JC, Baxter JD (1976) Solubilized nuclear "receptors" for thyroid hormones. Physical characteristics and binding properties, evidence for multiple forms. J Biol Chem 251(23):7388-7397
26. Lazar MA (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14(2):184-193. doi: 10.1210/edrv-14-2-184
27. Li YL, Litten C, Koehler KF, Mellstrom K, Garg N, Garcia Collazo AM, Farnegard M, Grynfarb M, Husman B, Sandberg J, Malm J (2006) Thyroid receptor ligands. Part 4: 4′-amido bioisosteric ligands selective for the thyroid hormone receptor beta. Bioorg Med Chem Lett 16(4):884-886. doi: 10.1016/j.bmcl.2005.11.002
28. Malm J, Grover GJ, Farnegardh M (2007) Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor. Mini Rev Med Chem 7(1):79-86. doi: 10.2174/138955707779317885
29. Martinez L, Nascimento AS, Nunes FM, Phillips K, Aparicio R, Dias SM, Figueira AC, Lin JH, Nguyen P, Apriletti JW, Neves FA, Baxter JD, Webb P, Skaf MS, Polikarpov I (2009) Gaining ligand selectivity in thyroid hormone receptors via entropy. Proc Natl Acad Sci USA 106(49):20717-20722. doi: 10.1073/pnas.0911024106
30. Mazák K, Tóth G, Kökösi J, Noszál B (2012) Thyroxine lipophilicity is dominated by its zwitterionic microspecies. Eur J Pharm Sci 47(5):921-925. doi: 10.1016/j.ejps.2012.09.009
31. Mohan V, Gibbs AC, Cummings MD, Jaeger EP, DesJarlais RL (2005) Docking: successes and challenges. Curr Pharm Des 11(3):323-333. doi: 10.2174/1381612053382106
32. Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Neto Oliveira M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov I (2006) Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J Mol Biol 360(3):586-598. doi: 10.1016/j.jmb.2006.05.008
33. Natesan S, Wang T, Lukacova V, Bartus V, Khandelwal A, Balaz S (2011) Rigorous treatment of multispecies multimode ligand receptor interactions in 3D-QSAR: CoMFA analysis of thyroxine analogs binding to transthyretin. J Chem Inf Model 51(5):1132-1150. doi: 10.1021/ci200055s
34. Noszal B (1990) Acid-base properties of bioligands. In: Burger K (ed) Biocoordination chemistry: coordination equilibria in biologically active system. Ellis Horwood, Chichester, pp 18-55
35. Park MS, Gao C, Stern HA (2011) Estimating binding affinities by docking/scoring methods using variable protonation states. Proteins 79(1):304-314. doi: 10.1002/prot.22883
36. Polgar T, Magyar C, Simon I, Keserü GM (2007) Impact of ligand protonation on virtual screening against beta-secretase (BACE1). J Chem Inf Model 47(6):2366-2377. doi: 10.1021/ci700223p
37. Raval S, Raval P, Bandyopadhyay D, Soni K, Yevale D, Jogiya D, Modi H, Joharapurkar A, Gandhi N, Jain MR, Patel PR (2008) Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands. Bioorg Med Chem Lett 18(14):3919-3924. doi: 10.1016/j.bmcl.2008.06.038
38. Rester U (2006) Dock around the clock-current status of small molecule docking and scoring. QSAR Comb Sci 25(7):605-616. doi: 10.1002/qsar.200510183
39. Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, Juric S, Nilsson S, Wagner R, Fletterick RJ, Baxter JD (2004) Thyroxine-thyroid hormone receptor interactions. J Biol Chem 279(53):55801-55808. doi: 10.1074/jbc.M410124200
40. Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221-234. doi: 10.1007/s10822-013-9644-8
41. Schrödinger Suite (2011) Protein Preparation Wizard, Epik version 2.2, Schrödinger, LLC, New York, NY, 2011; Impact version 5.7, Schrödinger, LLC, New York, NY, 2011; Prime version 3.0, Schrödinger, LLC, New York, NY, 2011
42. Shibusawa N, Hollenberg AN, Wondisford FE (2003) Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem 278(2):732-738. doi: 10.1074/jbc.M207264200
43. Stathatos N (2012) Thyroid physiology. Med Clin North Am 96(2):165-173. doi: 10.1016/j.mcna.2012.01.007
44. ten Brink T, Exner TE (2010) pK(a) based protonation states and microspecies for protein-ligand docking. J Comput Aided Mol Des 24(11):935-942. doi: 10.1007/s10822-010-9385-x
45. Toth G, Hosztafi S, Kovacs Z, Noszal B (2012) The site-specific basicity of thyroid hormones and their precursors as regulators of their biological functions. J Pharm Biomed Anal 61:156-164. doi: 10.1016/j.jpba.2011.11.020
46. Toth G, Mazak K, Hosztafi S, Kokosi J, Noszal B (2013) Species-specific lipophilicity of thyroid hormones and their precursors in view of their membrane transport properties. J Pharm Biomed Anal 76:112-118. doi: 10.1016/j.jpba.2012. 12.010
47. Wagner RL, Huber BR, Shiau AK, Kelly A, Cunha Lima ST, Scanlan TS, Apriletti JW, Baxter JD, West BL, Fletterick RJ (2001) Hormone selectivity in thyroid hormone receptors. Mol Endocrinol 15(3):398-410. doi: 10.1210/me.15.3.398
48. Wilson BD, Gent WL (1985) Effects of pH and ionic strength on the binding of L-tri-iodothyronine to the solubilized nuclear receptor. Biochem J 232(3):663-667
49. Ye L, Li YL, Mellstrom K, Mellin C, Bladh LG, Koehler K, Garg N, Garcia Collazo AM, Litten C, Husman B, Persson K, Ljunggren J, Grover G, Sleph PG, George R, Malm J (2003) Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. J Med Chem 46(9):1580-1588. doi: 10.1021/jm021080f